CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

PURPOSE: The present study is to investigate the significance of CD44 variant 9 (CD44v9) expression as a biomarker in primary gastric cancer. MATERIALS AND METHODS: With various gastric tissues, we performed immunohistochemical staining for CD44v9. RESULTS: The positive expression rates for CD44v9 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Se-Il, Ko, Gyung Hyuck, Lee, Won Sup, Kim, Rock Bum, Lee, Jeong-Hee, Jeong, Sang-Ho, Lee, Young-Joon, Hong, Soon Chan, Ha, Woo Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720095/
https://www.ncbi.nlm.nih.gov/pubmed/25779358
http://dx.doi.org/10.4143/crt.2014.227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720095/
https://www.ncbi.nlm.nih.gov/pubmed/25779358
http://dx.doi.org/10.4143/crt.2014.227

Ejemplares similares